Showing results (361-370 of 388) with videos related to
Sort By:
Pageof 39
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 3, 2015
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitisSumio Watanabe, Etsuko Hashimoto, Kenichi Ikejima, et al.Cancers|August 25, 2019
Third Epidemiological Analysis of Nasopharyngeal Carcinoma in the Central Region of Japan from 2006 to 2015Masafumi Kanno, Norihiko Narita, Yasushi Fujimoto, et al.Digestion|January 11, 2018
Improved Visibility of Barrett's Esophagus with Linked Color Imaging: Inter- and Intra-Rater Reliability and Quantitative AnalysisTsutomu Takeda, Akihito Nagahara, Kei Ishizuka, et al.Scientific Reports|October 15, 2016
Serum YKL-40 as a marker of liver fibrosis in patients with non-alcoholic fatty liver diseaseErina Kumagai, Yohei Mano, Sachiyo Yoshio, et al.Brain Communications|April 15, 2024
Tryptophan metabolism and small fibre neuropathy: a correlation studyHanae Kushibiki, Hiroki Mizukami, Sho Osonoi, et al.Plos One|June 22, 2012
Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in JapaneseTakahisa Kawaguchi, Yoshio Sumida, Atsushi Umemura, et al.Annals of Hematology|July 1, 2016
Incidence and clinical background of hepatitis B virus reactivation in multiple myeloma in novel agents' eraYutaka Tsukune, Makoto Sasaki, Takeshi Odajima, et al.Auris, Nasus, Larynx|March 24, 2018
Multicenter phase I/II study of chemoradiotherapy with high-dose CDDP for head and neck squamous cell carcinoma in JapanHiroshi Matsuyama, Keisuke Yamazaki, Ryuichi Okabe, et al.Journal of Gastroenterology|February 19, 2014
A randomized, placebo-controlled, double-blind clinical trial of rikkunshito for patients with non-erosive reflux disease refractory to proton-pump inhibitor: the G-PRIDE studyKazunari Tominaga, Mototsugu Kato, Hiroshi Takeda, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2024
Apalutamide and Goserelin for Androgen Receptor-Positive Salivary Gland Carcinoma: A Phase II Nonrandomized Clinical Trial, YATAGARASUYoshitaka Honma, Nobuya Monden, Keisuke Yamazaki, et al.Pageof 39